The profile of urinary metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats is determined by its pulmonary metabolism

Chemico-Biological Interactions

Volumn 118, Issue 3, 1999, Pages 247-266

  Schneider, Thomas ^a   Frei, Eva ^a   Wiessler, Manfred ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Acetone; Glucuronide; Hepatocytes; Nicotine; NNAL; NNK; Phenethyl isothiocyanate; Phenobarbital; Primary lung cells

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ACETONE; NICOTINE; NITROSAMINE; PHENETHYL ISOTHIOCYANATE; PHENOBARBITAL; PYRIDINE;

AEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONJUGATION; CONTROLLED STUDY; GLUCURONIDATION; HYDROXYLATION; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER CELL; LUNG; LUNG ALVEOLUS CELL; MALE; METABOLITE; NONHUMAN; OXIDATION; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TOBACCO; URINARY EXCRETION; XENOBIOTIC METABOLISM;

ANIMALS; CARCINOGENS; CELL SEPARATION; LIVER; LUNG; MALE; NITROSAMINES; RATS; RATS, INBRED F344;

NICOTIANA TABACUM;

EID: 0032960335     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(99)00083-6     Document Type: Article

References (40)

1. Hecht S.S., Hoffmann D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis. 9:1988;875-884.
2. Hecht S.S., Hoffmann D. The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surv. 8:1989;273-294.
3. Hoffmann D., Brunnemann K.D., Prokopczyk B., Djordjevic M.V. Tobacco-specific nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J. Toxicol. Environ. Health. 41:1994;1-52.
4. Belinsky S.A., White C.M., Trushin N., Hecht S.S. Cell specificity for the pulmonary metabolism of tobacco-specific nitrosamines in the Fisher rat. Carcinogenesis. 10:1989;2269-2274.
5. Peterson L.A., Mathew R., Hecht S.S. Quantitation of microsomal α-hydroxylation of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 51:1991;5495-5500.
6. Smith T.J., Guo Z., Gonzales F.J., Guengerich F.P., Stoner G.D., Yang C.S. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells. Cancer Res. 52:1992;1757-1763.
7. Maser E., Richter E., Friebertshäuser J. The identification of 11β-hydroxysteroid dehydrogenase as carbonyl reductase of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Eur. J. Biochem. 238:1996;484-489.
8. Smith T.J., Stoner G.D., Yang C.S. Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase and hydroperoxides. Cancer Res. 55:1995;5566-5573.
9. Hecht S.S., Trushin N., Castonguay A., Rivenson A. Comparative tumorigenicity and DNA methylation in F344 rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosodimethylamine. Cancer Res. 46:1986;498-502.
10. Hecht S.S., Spratt T.E., Trushin N. Evidence for 4-(3-pyridyl)-4-oxobutylation of DNA in F344 rats treated with the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N′-nitrosonornicotine. Carcinogenesis. 9:1988;161-165.
11. Belinsky S.A., White C.M., Boucheron J.A., Richardson F.C., Swenberg J.A., Anderson M. Accumulation and persistence of DNA adducts in respiratory tissue of rats following multiple administration of the tobacco specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 46:1986;1280-1284.
12. Morse M.A., Eklind K.I., Toussaint M., Amin S.G., Chung F.-L. Characterization of a glucuronide metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats. Carcinogenesis. 11:1990;1819-1823.
13. Wiench K., Frei E., Schroth P., Wiessler M. 1-C-glucuronidation of N-nitrosodiethylamine and N-nitrosomethyl-n-pentylamine in vivo and in primary hepatocytes from rats pretreated with inducers. Carcinogenesis. 13:1992;867-872.
14. Murphy S.E., Spina D.A., Nunes M.G., Pullo D.A. Glucuronidation of 4-(hydroxymethylnitrosamino)-1-(3-pyridyl)-1-butanone, a metabolically activated form of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, by phenobarbital-treated rats. Chem. Res. Toxicol. 8:1995;772-779.
15. Kim P.M., Wells P.G. Genoprotection by UDP-glucuronosyltransferases in peroxidase-dependent reactive oxygen species-mediated micronucleus initiation by the carcinogens 4-(methylnitrosamino)-1-(3pyridyl)-1-butanone and benzo[a]pyrene. Cancer Res. 56:1996;1526-1532.
16. Guo Z., Smith T.J., Thomas P.E., Yang C.S. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by inducible and constitutive cytochrome P450 enzymes in rats. Arch. Biochem. Biophys. 298:1992;279-282.
17. Lacroix D., Descroches M., Castonguay A., Anderson A. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human kidney epithelial cells transfected with rat CYP2B1 cDNA. Carcinogenesis. 14:1993;1639-1642.
18. Morse M.A., Wang C.-X., Stoner G.D., Mandal S., Conran P.B., Amin S.G., Hecht S.S., Chung F.-L. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct formation and tumorigenicity in the lung of F344 rats by dietary phenethyl isothiocyanate. Cancer Res. 49:1989;549-553.
19. Smith T.J., Guo Z., Ning S.M., Thomas P.E., Yang C.S. Mechanisms of inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation by dietary phenethyl isothiocyanate. Cancer Res. 53:1993;3276-3282.
20. Hecht S.S. Chemoprevention by isothiocyanates. J. Cell. Biochem. 22((Supplement)):1995;195-209.
21. Fischer S., Spiegelhalder B., Eisenbarth J., Preussmann R. Investigations of the origin of tobacco-specific nitrosamines in mainstream smoke of cigarettes. Carcinogenesis. 11:1990;723-730.
22. Tricker A.R., Ditrich C., Preussmann R. N-nitroso compounds in cigarette tobacco and their occurrence in mainstream smoke. Carcinogenesis. 12:1991;257-261.
23. Murphy S.E., Heilblum R. Effect of nicotine and tobacco-specific nitrosamines on the metabolism of N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by rat oral tissue. Carcinogenesis. 11:1990;1663-1666.
24. Richter E., Tricker A.R. Nicotine inhibits the metabolic activation of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis. 15:1994;1061-1064.
25. Benford D.J., Hubbard S.A. Preparation and culture of mammalian cells. Snell K., Mullock B. Biochemical Toxicology, A Practical Approach. 1987;57-82 IRL Press, Oxford.
26. Bundschuh D.S., Uhlig S., Wendel A. Isolation of rat primary lung cells: characterization of an improved method. Exp. Toxicol. Pathol. 48:1996;512-514.
27. Hecht S.S. Biochemistry, biology and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol. 11:1998;559-603.
28. Foth H. Role of the lung in accumulation and metabolism of xenobiotic compounds - implications for chemically induced toxicity. CRC Crit. Rev. Toxicol. 25:1995;165-205.
29. Bond J.A. Metabolism and elimination of inhaled drugs and airborne chemicals from the lungs. Pharmacol. Toxicol. 72(Suppl. 3):1993;36-47.
30. 6-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 50:1990;3772-3780.
31. Belinsky S.A., White C.M., Devereux T.R., Swenberg J.A., Anderson M.W. Cell selective alkylation of DNA in rat lung following low dose exposure to the tobacco-specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 47:1987;1143-1148.
32. Murphy S.E., Nunes M.G., Hatala M.A. Effects of phenobarbital and 3-methylcholanthrene induction on the formation of three glucuronide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, NNK. Chem.-Biol. Interact. 103:1997;153-166.
33. Ebner T., Burchell B. Substrate specificity of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. Drug Metabol. Dispos. 21:1993;50-55.
34. Wooster R., Sutherland L., Ebner T., Clarke D., Da Cruz O., Silva E, Burchell B. Cloning and stable expression of a new member of the human liver phenolbilirubin: UDP-glucuronosyltransferase cDNA family. Biochem. J. 278:1991;465-469.
35. Smith T.J., Guo Z., Thomas P.E., Chung F.-L., Morse M.A., Eklind K., Yang C.S. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes and its inhibition by isothiocyanates. Cancer Res. 50:1990;6817-6822.
36. Staretz M.E., Koenig L.-A.A., Hecht S.S. Effects of long term dietary phenethyl isothiocyanate on the microsomal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats. Carcinogenesis. 18:1997;1715-1722.
37. Smith T.J., Guo Z., Guengerich F.P., Yang C.S. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate. Carcinogenesis. 17:1996;809-813.
38. Kyerematen G.A., Vesell E.S. Metabolism of nicotine. Drug Metabol. Rev. 23:1991;3-41.
39. Takenaka O., Horie T., Suzuki H., Sugiyama Y. Carrier-mediated active transport of the glucuronide and sulfate of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole (E3040) into rat liver: quantitative comparison of permeability in isolated hepatocytes, perfused liver and liver in vivo. J. Pharmcol. Exp. Ther. 280:1997;948-958.
40. Atawodi S.E., Michelsen K., Richter E. Metabolism of a glucuronide conjugate of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats. Arch. Toxicol. 69:1994;14-17.